Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity

Cancer Cell
Christopher DravisGeoffrey M Wahl

Abstract

Cell state reprogramming during tumor progression complicates accurate diagnosis, compromises therapeutic effectiveness, and fuels metastatic dissemination. We used chromatin accessibility assays and transcriptional profiling during mammary development as an agnostic approach to identify factors that mediate cancer cell state interconversions. We show that fetal and adult basal cells share epigenetic features consistent with multi-lineage differentiation potential. We find that DNA-binding motifs for SOX transcription factors are enriched in chromatin that is accessible in stem/progenitor cells and inaccessible in differentiated cells. In both mouse and human tumors, SOX10 expression correlates with stem/progenitor identity, dedifferentiation, and invasive characteristics. Strikingly, we demonstrate that SOX10 binds to genes that regulate neural crest cell identity, and that SOX10-positive tumor cells exhibit neural crest cell features.

Citations

Mar 22, 2019·International Journal of Radiation Biology·Claudia PeitzschMichael Baumann
Dec 27, 2019·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Geula Hanin, Anne C Ferguson-Smith
Oct 12, 2019·Nature Reviews. Drug Discovery·Soufiane Boumahdi, Frederic J de Sauvage
Sep 21, 2019·Physiological Reviews·Nai Yang FuJane E Visvader
Jul 4, 2019·The EMBO Journal·Pirashaanthy TharmapalanRama Khokha
Apr 25, 2019·International Journal of Molecular Sciences·Pei-Yi ChuChang-Shen Lin
May 10, 2019·Journal of Mammary Gland Biology and Neoplasia·Gaurav A MehtaMichael L Gatza
May 14, 2020·Cells·Flavia Lima Costa FaldoniSilvia Regina Rogatto
Jun 2, 2020·Frontiers in Molecular Biosciences·Jean Paul Vernot
Oct 25, 2020·Development·Weiyi Tang, Marianne E Bronner
Apr 11, 2019·Molecular Cancer Research : MCR·Outhiriaradjou BenardRachel B Hazan
Feb 7, 2021·Nature Reviews. Cancer·Arthur W Lambert, Robert A Weinberg
Feb 11, 2021·Genes·Elitsa IvanovaFabienne Le Provost
Feb 16, 2021·Seminars in Cell & Developmental Biology·Yu Liu, Wenjun Guo
Jan 22, 2021·Seminars in Cell & Developmental Biology·Elena Spina, Pamela Cowin
Feb 25, 2021·Journal of Mammary Gland Biology and Neoplasia·Yorick Bernardus Cornelis van de GriftRenée van Amerongen
Apr 1, 2021·Clinical Epigenetics·Federica SarnoUNKNOWN International Network Medicine Consortium
Apr 4, 2021·Seminars in Cell & Developmental Biology·Alecia-Jane Twigger, Walid T Khaled
Apr 21, 2021·Developmental Cell·Igor L BadoXiang H-F Zhang
May 15, 2021·Breast Cancer Research : BCR·Khalid N Al-ZahraniLuc A Sabourin
May 19, 2021·Histochemistry and Cell Biology·Isadora F G SenaAlexander Birbrair
Jun 3, 2021·Cancers·Heidie Frisco Cabanos, Aaron N Hata
Jul 1, 2021·Breast Cancer Research : BCR·Bhupinder PalJane E Visvader
Aug 4, 2021·Reproductive Toxicology·Thalles Fernando Rocha RuizEllen Cristina Rivas Leonel
Dec 4, 2021·Signal Transduction and Targeted Therapy·Liping ZhongYongxiang Zhao
Jan 14, 2022·Cancer Discovery·Douglas Hanahan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.